ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,734Medicare Part D Prescriptions Filled, Including Refills

Rank: 856 out of 3593

$412K Total Retail Price of All Prescriptions

Rank: 911 out of 3593

388 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 388 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,738 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 389 331 1 2
LEVOTHYROXINE SODIUM 350 316 2 4
PRAVASTATIN SODIUM 308 268 3 13
CRESTOR 303 279 4 21
ATENOLOL 238 235 5 11
AMLODIPINE BESYLATE 185 171 6 3
ATORVASTATIN CALCIUM 181 172 7 15
IRBESARTAN 177 160 8 258
FUROSEMIDE 151 118 9 9
VERAPAMIL ER 146 129 10 99
DIOVAN 145 137 11 46
METOPROLOL TARTRATE 140 128 12 8
HYDROCHLOROTHIAZIDE 133 125 13 10
SIMVASTATIN 122 96 14 1
ZOLPIDEM TARTRATE 115 112 15 12
POTASSIUM CHLORIDE 107 104 16 24
METFORMIN HCL 101 97 17 6
WARFARIN SODIUM 100 97 18 18
PANTOPRAZOLE SODIUM 97 89 19 45
GLYBURIDE-METFORMIN HCL 96 63 R 20 95
RANITIDINE HCL 95 80 21 27
HYDROCODONE-ACETAMINOPHEN 84 55 S3 22 7
AZITHROMYCIN 83 70 23 34
METOPROLOL SUCCINATE 82 65 24 19
TAMSULOSIN HCL 79 72 25 33
LOSARTAN POTASSIUM 75 64 26 14
ALLOPURINOL 74 69 27 35
FLUTICASONE PROPIONATE 74 72 27 32
NEXIUM 73 58 29 36
GABAPENTIN 70 59 30 16
AVAPRO 70 69 30 376
LANTUS 69 47 32 57
ACTOS 67 58 33 133
OMEPRAZOLE 64 43 34 5
CELEBREX 63 63 35 100
SERTRALINE HCL 59 58 36 28
ENALAPRIL MALEATE 59 58 36 38
CARVEDILOL 57 35 38 23
ALENDRONATE SODIUM 56 50 39 22
TRICOR 56 56 39 130
CITALOPRAM HBR 55 47 41 25
RAMIPRIL 52 38 42 92
DICLOFENAC SODIUM 51 51 43 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.